These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15280786)

  • 21. The chemokine receptor, CCR5.
    Mueller A; Strange PG
    Int J Biochem Cell Biol; 2004 Jan; 36(1):35-8. PubMed ID: 14592532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Porphyromonas gingivalis selectively up-regulates the HIV-1 coreceptor CCR5 in oral keratinocytes.
    Giacaman RA; Nobbs AH; Ross KF; Herzberg MC
    J Immunol; 2007 Aug; 179(4):2542-50. PubMed ID: 17675516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 infection in a man homozygous for CCR5 delta 32.
    O'Brien TR; Winkler C; Dean M; Nelson JA; Carrington M; Michael NL; White GC
    Lancet; 1997 Apr; 349(9060):1219. PubMed ID: 9130945
    [No Abstract]   [Full Text] [Related]  

  • 24. The effects of the 32-bp CCR-5 deletion on HIV transmission and HIV disease progression in individuals with haemophilia.
    Pasi KJ; Sabin CA; Jenkins PV; Devereux HL; Ononye C; Lee CA
    Br J Haematol; 2000 Oct; 111(1):136-42. PubMed ID: 11091193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between a phenotypic assay and three bioinformatic tools for determining HIV co-receptor use.
    Poveda E; Briz V; Roulet V; Del Mar González M; Faudon JL; Skrabal K; Soriano V
    AIDS; 2007 Jul; 21(11):1487-90. PubMed ID: 17589199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors.
    Cohen OJ; Vaccarezza M; Lam GK; Baird BF; Wildt K; Murphy PM; Zimmerman PA; Nutman TB; Fox CH; Hoover S; Adelsberger J; Baseler M; Arthos J; Davey RT; Dewar RL; Metcalf J; Schwartzentruber DJ; Orenstein JM; Buchbinder S; Saah AJ; Detels R; Phair J; Rinaldo C; Margolick JB; Pantaleo G; Fauci AS
    J Clin Invest; 1997 Sep; 100(6):1581-9. PubMed ID: 9294127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance to HIV-1 infection: it's in the genes.
    Fauci AS
    Nat Med; 1996 Sep; 2(9):966-7. PubMed ID: 8782446
    [No Abstract]   [Full Text] [Related]  

  • 28. [Analysis of the 32 bp deletion in the CCR5 chemokine receptor gene in people from Moscow, infected with HIV-1].
    Shadrina MI; Kapylov VM; Miloserdova OV; Slominskiĭ PA; Limborskaia SA
    Genetika; 2000 May; 36(5):718-20. PubMed ID: 10867893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic effects on HIV disease progression.
    Ioannidis JP; O'Brien TR; Rosenberg PS; Contopoulos-Ioannidis DG; Goedert JJ
    Nat Med; 1998 May; 4(5):536. PubMed ID: 9585207
    [No Abstract]   [Full Text] [Related]  

  • 30. Distribution of the HIV resistance CCR5-Delta32 allele among Egyptians and Syrians.
    Salem AH; Batzer MA
    Mutat Res; 2007 Mar; 616(1-2):175-80. PubMed ID: 17166523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations of CCR5, CCR2, and stromal cell-derived factor 1 genotypes with human immunodeficiency virus disease progression in patients receiving nucleoside therapy.
    Lathey JL; Tierney C; Chang SY; D'Aquila RT; Bettendorf DM; Alexander HC; Santini CD; Hughes AM; Barroga CF; Spector SA; Landes JE; Hammer SM; Katzenstein DA
    J Infect Dis; 2001 Dec; 184(11):1402-11. PubMed ID: 11709782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemokines and HIV-1 second receptors: the therapeutic connection.
    Cairns JS; D'Souza MP
    Nat Med; 1998 May; 4(5):563-8. PubMed ID: 9585229
    [No Abstract]   [Full Text] [Related]  

  • 33. 32 bp CCR-5 gene deletion and resistance to fast progression in HIV-1 infected heterozygotes.
    Rappaport J; Cho YY; Hendel H; Schwartz EJ; Schachter F; Zagury JF
    Lancet; 1997 Mar; 349(9056):922-3. PubMed ID: 9093257
    [No Abstract]   [Full Text] [Related]  

  • 34. Polymorphisms of CCR5 gene in a southern Chinese population and their effects on disease progression in HIV infections.
    Zheng BJ; Zhao XY; Zhu NS; Chan CP; Wong KH; Chan KC; Yam WC; Yuen KY; Lee SS
    AIDS; 2002 Dec; 16(18):2480-2. PubMed ID: 12461425
    [No Abstract]   [Full Text] [Related]  

  • 35. Position 22 of the V3 loop is associated with HIV infectivity.
    Wei XM; Xu HF; Cheng XD; Bu N; Zhou HZ
    Arch Virol; 2017 Mar; 162(3):637-643. PubMed ID: 27815696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Identification of new mutant sites and 894C deletion variant genotyping of HIV-1 coreceptor CCR5 in indigenous Chinese populations].
    Liu M; Wang F; Hong W; Wang B; Jin L; Lei Z; Hou J
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1468-72. PubMed ID: 12509908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peptide mimotopes selected with HIV-1-blocking monoclonal antibodies against CCR5 represent motifs specific for HIV-1 entry.
    Königs C; Pustowka A; Irving J; Kessel C; Klich K; Wegner V; Rowley MJ; Mackay IR; Kreuz W; Griesinger C; Dietrich U
    Immunol Cell Biol; 2007 Oct; 85(7):511-7. PubMed ID: 17607321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional analysis of naturally occurring mutations in the open reading frame of CCR5 in HIV-infected Chinese patients and healthy controls.
    Zhao XY; Lee SS; Wong KH; Chan KC; Ng F; Chan CC; Han D; Yam WC; Yuen KY; Ng MH; Zheng BJ
    J Acquir Immune Defic Syndr; 2005 Apr; 38(5):509-17. PubMed ID: 15793360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy.
    O'Brien TR; McDermott DH; Ioannidis JP; Carrington M; Murphy PM; Havlir DV; Richman DD
    AIDS; 2000 May; 14(7):821-6. PubMed ID: 10839590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression.
    Huang Y; Paxton WA; Wolinsky SM; Neumann AU; Zhang L; He T; Kang S; Ceradini D; Jin Z; Yazdanbakhsh K; Kunstman K; Erickson D; Dragon E; Landau NR; Phair J; Ho DD; Koup RA
    Nat Med; 1996 Nov; 2(11):1240-3. PubMed ID: 8898752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.